IGC Pharma News

IGC Pharma | 8-K: Current report

16:11 ET

IGC Pharma | 4: Statement of changes in beneficial ownership of securities-Director Moran James P

16:11 ET

IGC Pharma | 8-K: Current report

Aug 27 13:19 ET

IGC Pharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Bradbury Strategic Investment Fund A(18.3%)

Aug 14 16:28 ET

IGC Pharma | 4: Statement of changes in beneficial ownership of securities-Director PRINS RICHARD K

Aug 12 09:31 ET

IGC Pharma | 144: Notice of proposed sale of securities pursuant to Rule 144

Aug 9 18:08 ET

IGC Pharma | 10-Q: Q1 2025 Earnings Report

Aug 7 16:08 ET

IGC Pharma | 8-K: Current report

Aug 2 14:39 ET

IGC Pharma | DEFA14A: Others

Jul 9 14:21 ET

IGC Pharma | DEF 14A: Definitive information statements

Jul 8 16:08 ET

IGC Pharma | 10-K: FY2024 Annual Report

Jun 24 13:35 ET

IGC Pharma | SC 13D: Statement of acquisition of beneficial ownership by individuals-Bradbury Strategic Investment Fund A(18.3%)

May 21 21:25 ET

IGC Pharma | 4: Statement of changes in beneficial ownership of securities-10% Owner Bradbury Strategic Investment Fund A (Cayman Islands Registration No. CR-359857)

May 13 21:59 ET

IGC Pharma | 3: Initial statement of beneficial ownership of securities- Bradbury Strategic Investment Fund A (Cayman Islands Registration No. CR-359857)

May 13 21:54 ET

IGC Pharma | EFFECT: Others

May 3 06:06 ET

IGC Pharma | CORRESP: CORRESP

Apr 30 13:31 ET

IGC Pharma | UPLOAD: Others

Apr 19 13:31 ET

IGC Pharma | S-3: Registration statement for specified transactions by certain issuers

Apr 18 13:17 ET

IGC Pharma | 8-K: Current report

Apr 5 11:38 ET

IGC Pharma | 8-K: Current report

Mar 28 13:07 ET